Shandong Chenghui

Shandong Chenghui Pharmaceutical is a comprehensive pharmaceutical enterprise based in Jinan, China, focusing on the development and production of high-end Active Pharmaceutical Ingredients (APIs) and finished drug products. The company has established a strong reputation for its expertise in peptide synthesis and complex small molecule chemistry, supporting a diverse portfolio of metabolic, cardiovascular, and oncology treatments. Shandong Chenghui operates multiple state-of-the-art manufacturing facilities that comply with international GMP standards, enabling it to serve as a key supplier to global markets. In addition to its product catalog, the company provides contract development and manufacturing (CDMO) services, leveraging its R&D capabilities to assist partners in process optimization and scale-up. Their strategic focus on high-growth areas like GLP-1 agonists has positioned them as a significant player in the peptide drug industry.